Trust Stamp makes first LLM-focused AI Patent filing for Medical Diagnosis Assurance
Atlanta, GA, July 02, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) Gareth N. Genner, Chief Executive Officer of the Company commented, “Prior to this we had a total of twenty seven issued or allowed patents and seven patents pending, covering a range of proprietary technologies encompassing AI, Biometrics and cryptography. On June 15, 2026 we filed U.S. Provisional Patent Application No. 64/091,057 entitled: “Medical Diagnostic Assurance System” (“MDAS”) for an LLM-based technology desi
Atlanta, GA, July 02, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) Gareth N. Genner, Chief Executive Officer of the Company commented, “Prior to this we had a total of twenty seven issued or allowed patents and seven patents pending, covering a range of proprietary technologies encompassing AI, Biometrics and cryptography. On June 15, 2026 we filed U.S. Provisional Patent Application No. 64/091,057 entitled: “Medical Diagnostic Assurance System” (“MDAS”) for an LLM-based technology designed to avoid critical issues in medical diagnosis including confirmation bias amplification, and hallucinations that could cite invented data sources.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.